Ongoing Transmission of Candida auris in Health Care Facilities – United States, June 2016-May 2017.

June 27, 2017 at 8:22 am

MMWR Morb Mortal Wkly Rep. May 19, 2017  V.66 N.19 P.514-515.

Notes from the Field:

Tsay S, Welsh RM, Adams EH, Chow NA, Gade L, Berkow EL, Poirot E, Lutterloh E, Quinn M, Chaturvedi S, Kerins J, Black SR, Kemble SK, Barrett PM; MSD, Barton K, Shannon DJ, Bradley K, Lockhart SR, Litvintseva AP, Moulton-Meissner H, Shugart A, Kallen A, Vallabhaneni S, Chiller TM, Jackson BR.

In June 2016, CDC released a clinical alert about the emerging, and often multidrug-resistant, fungus Candida auris and later reported the first seven U.S. cases of infection through August 2016 (1).

Six of these cases occurred before the clinical alert and were retrospectively identified. As of May 12, 2017, a total of 77 U.S. clinical cases of C. auris had been reported to CDC from seven states: New York (53 cases), New Jersey (16), Illinois (four), Indiana (one), Maryland (one), Massachusetts (one), and Oklahoma (one) (Figure).

All of these cases were identified through cultures taken as part of routine patient care (clinical cases).

Screening of close contacts of these patients, primarily of patients on the same ward in health care facilities, identified an additional 45 patients with C. auris isolated from one or more body sites (screening cases), resulting in a total of 122 patients from whom C. auris has been isolated……


Entry filed under: Antimicoticos, Biología Molecular, Epidemiología, Infecciones emergentes, Infecciones micoticas, Metodos diagnosticos, REPORTS, Sepsis, Update.

Candida auris candidaemia in Indian ICUs: analysis of risk factors Rapid and accurate molecular identification of the emerging multidrug resistant pathogen Candida auris.


June 2017
« May   Jul »

Most Recent Posts

%d bloggers like this: